These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 21842146)
1. Impact of diabetes on postinfarction heart failure and left ventricular remodeling. von Bibra H; St John Sutton M Curr Heart Fail Rep; 2011 Dec; 8(4):242-51. PubMed ID: 21842146 [TBL] [Abstract][Full Text] [Related]
2. A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload. Raher MJ; Thibault HB; Buys ES; Kuruppu D; Shimizu N; Brownell AL; Blake SL; Rieusset J; Kaneki M; Derumeaux G; Picard MH; Bloch KD; Scherrer-Crosbie M Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2495-502. PubMed ID: 18978196 [TBL] [Abstract][Full Text] [Related]
3. Diabetes and heart failure in the post-myocardial infarction patient. Estep JD; Aguilar D Curr Heart Fail Rep; 2006 Dec; 3(4):164-9. PubMed ID: 17129509 [TBL] [Abstract][Full Text] [Related]
4. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction. Poulsen SH Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125 [TBL] [Abstract][Full Text] [Related]
5. Manifestation of adaptive changes during combined development of postinfarction remodeling of the heart and diabetes mellitus. Egorova MV; Afanas'ev SA; Popov SV; Karpov RS Bull Exp Biol Med; 2010 Dec; 150(2):172-4. PubMed ID: 21240364 [TBL] [Abstract][Full Text] [Related]
6. Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes. Matsushima S; Kinugawa S; Yokota T; Inoue N; Ohta Y; Hamaguchi S; Tsutsui H Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H409-16. PubMed ID: 19465539 [TBL] [Abstract][Full Text] [Related]
7. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Paulus WJ; Tschöpe C J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677 [TBL] [Abstract][Full Text] [Related]
8. Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis. Høfsten DE; Løgstrup BB; Møller JE; Pellikka PA; Egstrup K JACC Cardiovasc Imaging; 2009 May; 2(5):592-9. PubMed ID: 19442946 [TBL] [Abstract][Full Text] [Related]
9. The impact of diabetes on heart failure: opportunities for intervention. Skouri HN; Tang WH Curr Heart Fail Rep; 2007 Jun; 4(2):70-7. PubMed ID: 17521498 [TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure. Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957 [TBL] [Abstract][Full Text] [Related]
11. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. Yin M; van der Horst IC; van Melle JP; Qian C; van Gilst WH; Silljé HH; de Boer RA Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H459-68. PubMed ID: 21572014 [TBL] [Abstract][Full Text] [Related]
13. Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction. Marfella R; Verza M; Giugliano D Circulation; 2003 Apr; 107(13):e85; author reply e85. PubMed ID: 12682032 [No Abstract] [Full Text] [Related]
14. [Comparative study on early application of the recipe for activating blood circulation and the recipe for supplementing qi for inhibiting left ventricular remodeling and apoptosis in rats with heart failure]. Zhao MJ; Wang SR; Li M; Wang ZT; Zhu LQ; Cui W; Lu XY Zhongguo Zhong Yao Za Zhi; 2007 Apr; 32(8):710-4. PubMed ID: 17608227 [TBL] [Abstract][Full Text] [Related]
15. Insulin Signaling and Heart Failure. Riehle C; Abel ED Circ Res; 2016 Apr; 118(7):1151-69. PubMed ID: 27034277 [TBL] [Abstract][Full Text] [Related]
16. Modulation of left ventricular dilation remodeling with epicardial restraint devices in postmyocardial infarction heart failure. Topkara VK; Kondareddy S; Mann DL Curr Heart Fail Rep; 2009 Dec; 6(4):229-35. PubMed ID: 19948091 [TBL] [Abstract][Full Text] [Related]
17. Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats. Despa S; Margulies KB; Chen L; Knowlton AA; Havel PJ; Taegtmeyer H; Bers DM; Despa F Circ Res; 2012 Feb; 110(4):598-608. PubMed ID: 22275486 [TBL] [Abstract][Full Text] [Related]
18. Myocardial glucose transport and utilization: a target for therapeutic intervention. Singh PP; Lago RM; Nesto RW Rev Cardiovasc Med; 2008; 9(2):106-10. PubMed ID: 18660731 [TBL] [Abstract][Full Text] [Related]
19. Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance. Oikonomou E; Mourouzis K; Fountoulakis P; Papamikroulis GA; Siasos G; Antonopoulos A; Vogiatzi G; Tsalamadris S; Vavuranakis M; Tousoulis D Heart Fail Rev; 2018 May; 23(3):389-408. PubMed ID: 29453696 [TBL] [Abstract][Full Text] [Related]